Strata Critical Medical (SRTAW) Research & Development (2020 - 2025)
Historic Research & Development for Strata Critical Medical (SRTAW) over the last 6 years, with Q3 2025 value amounting to $453000.0.
- Strata Critical Medical's Research & Development rose 863.31% to $453000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 4225.21%. This contributed to the annual value of $3.2 million for FY2024, which is 3118.65% down from last year.
- Per Strata Critical Medical's latest filing, its Research & Development stood at $453000.0 for Q3 2025, which was up 863.31% from $915000.0 recorded in Q2 2025.
- Over the past 5 years, Strata Critical Medical's Research & Development peaked at $2.2 million during Q4 2024, and registered a low of $289000.0 during Q1 2021.
- Its 5-year average for Research & Development is $985315.8, with a median of $915000.0 in 2025.
- Per our database at Business Quant, Strata Critical Medical's Research & Development soared by 39647.06% in 2021 and then plummeted by 6124.54% in 2024.
- Quarter analysis of 5 years shows Strata Critical Medical's Research & Development stood at $702000.0 in 2021, then skyrocketed by 131.05% to $1.6 million in 2022, then tumbled by 39.09% to $988000.0 in 2023, then soared by 117.91% to $2.2 million in 2024, then tumbled by 78.96% to $453000.0 in 2025.
- Its Research & Development was $453000.0 in Q3 2025, compared to $915000.0 in Q2 2025 and $812000.0 in Q1 2025.